Please let me know what equation and which numbers are used to calculate what I have marked incorrect.

Forecast the Balance Sheet

Following is the balance sheet for Medtronic PLC for the year ended April 29, 2016.

Current assets
Cash and cash equivalents				$2,988	$4,843
Investments				9,758	14,637
Accounts receivable				5,562	5,112
Inventories				3,473	3,463
Tax assets				697	1,335
Prepaid expenses and other current assets				1,234	1,454
Total current assets				23,712	30,844
Property, plant, and equipment, net				4,841	4,699
Goodwill				41,500	40,530
Other intangible assets, net				26,899	28,101
Long-term tax assets				1,383	774
Other assets				1,559	1,737
Total assets				$99,894	$106,685
Current liabilities
Short-term borrowings				$1,105	$2,434
Accounts payable				1,709	1,610
Accrued compensation				1,712	1,611
Accrued income taxes				566	935
Deferred tax liabilities				-	119
Other accrued expenses				2,185	2,464
Total current liabilities				7,277	9,173
Long-term debt				30,247	33,752
Long-term accrued compensation				1,759	1,535
Long-term accrued income taxes				2,903	2,476
Long-term deferred tax liabilities				3,729	4,700
Other long-term liabilities				1,916	1,819
Total liabilities				47,831	53,455
Shareholders equity
Ordinary shares				-	-
Retained earnings				53,931	54,414
Accumulated other comprehensive (loss)				(1,868)	(1,184)
Total shareholders equity				52,063	53,230
Total liabilities and shareholders equity				$99,894	$106,685

Use the following assumptions to forecast the companys balance sheet for FY2017.

Forecasted FY2017 net income	$5,151 million
Forecasted FY2017 net sales	$36,274 million
Accounts receivable	19.3% of net sales
Inventories	12.0% of net sales
Tax assets	2.4% of net sales
Prepaid expenses and other current assets	4.3% of net sales
Long-term tax assets	4.8% of net sales
Other assets	5.4% of net sales
Accounts payable	5.9% of net sales
Accrued compensation	5.9% of net sales
Accrued income taxes	2.0% of net sales
Other accrued expenses	7.6% of net sales
Long-term accrued income taxes	10.1% of net sales
Long-term deferred tax liabilities	12.9% of net sales
Other long-term liabilities	6.6% of net sales
Investments	No change
Goodwill	No change
Long-term accrued compensation and retirement benefits	No change
Ordinary shares	No change
Accumulated other comprehensive (loss)	No change
CAPEX	3.6% of net sales
Depreciation expense	18.9% of prior year PPE, net
Amortization expense in FY2016	$1,931 million
Current maturities of debt due in FY2017	$1,105 million
Current maturities of debt due in FY2018	$6,176 million
Dividend payout ratio	60.5%

Round your answers to the nearest whole number.

Use a negative sign with your Accumulated other comprehensive loss answer.

Medtronic plcForecasted Consolidated Balance Sheet($ millions)EST. 2017